In line with our observations, the frequency of PD-1+CD8+ T cells relative to that of PD-1+ Treg cells in the TME predicted clinical efficacy of PD-1 blockade therapy in patients with advanced melanoma and gastric carcinoma43. Here, CD8A is linked to melanoma.